✦
High-fidelity Editing
Targeted CRISPR and base editing systems engineered for specificity, accuracy, and translational readiness.
Genomic Research Labs
Engineering the Future
of Precision Medicine
Genomic Research Labs is a Dallas-based biotech company focused on CRISPR gene therapy, translational discovery, and patient-centered genomic medicine. We design precise therapeutic interventions that move from molecular insight to real clinical opportunity.
CRISPR TherapeuticsTranslational ResearchPatient-Centered Genomics
0Therapy programs across rare and inherited diseases
0Years of research depth reflected in our platform
0Integrated innovation systems across edit, delivery, analytics, and care
0%+Editing efficiency target in validated model systems
Our Innovations
Precision platforms designed for real therapeutic progress
We build enabling technologies that strengthen the full gene therapy pathway — from guide design and editing chemistry to delivery, analytics, and translational validation.
◈
Delivery Science
Optimized delivery architectures supporting tissue-directed transport and therapeutic performance.
⌁
Data & Automation
Robotic workflows and genomic analytics designed to accelerate research with quality and repeatability.
Editing Efficiency>95%
Translational Pipeline
Therapies shaped by molecular precision
Our pipeline strategy is built around diseases where genomic correction can produce durable, clinically meaningful outcomes. We prioritize programs with strong biological rationale, clear patient need, and a realistic path to translation.
- Sickle Cell Disease
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Inherited Retinal Disorders
- Transthyretin Amyloidosis
For Patients
Clinical guidance with clarity and compassion
If you or a loved one is navigating a genetic condition, our team is prepared to help you understand the landscape. We are committed to transparent conversations, evidence-based guidance, and a respectful path from inquiry to clinical review.
Rare Disease Care
A patient-first vision from early life onward
We believe genomic medicine should be clinically meaningful and deeply human. Our work supports future programs relevant to pediatric, inherited, and rare-disease populations where early precision can have lifelong impact.
Research Partners & Funding Bodies
NIHBroad InstituteUCSFMITDARPAWellcome TrustGates Foundation
Automation & Scale
Technology infrastructure that accelerates discovery
From advanced instrumentation to robotic assistance and analytical control systems, our platform is designed for repeatability, speed, and translational confidence.
Automation
Instrument-driven workflows
Integrated equipment and digital process control improve experimental throughput and consistency.
Analytics
Genome-scale insight
Visual dashboards and sequencing-aware analysis help transform complex data into informed decisions.
Scientific Leadership
A multidisciplinary team built for translational impact
Genomic Research Labs brings together molecular biologists, clinicians, delivery scientists, and translational strategists with a shared purpose: move advanced genome engineering toward therapies that matter.
External News Feed
Weekly Genomics News
Recent external headlines in CRISPR, gene therapy, genomics, and precision medicine. No separate posts are created on this site.
AGBT Announces 2026 Precision Health Next Gen Leadership Award Recipients - businesswire.com
AGBT Announces 2026 Precision Health Next Gen Leadership Award Recipients businesswire.com
Read at source →Encoded raises $275M to advance gene therapy for Dravet syndrome - Dravet Syndrome News
Encoded raises $275M to advance gene therapy for Dravet syndrome Dravet Syndrome News
Read at source →RCKT: FDA clears pivotal Danon gene therapy trial; robust pipeline and cash runway support growth - TradingView
RCKT: FDA clears pivotal Danon gene therapy trial; robust pipeline and cash runway support growth TradingView
Read at source →
News is syndicated from external publishers through RSS. Headlines and summaries belong to their original sources.
Patients
Ready to explore your options?
Connect with our team in Dallas to discuss whether you or a family member may qualify for future therapeutic programs.
Collaborate
Advance genomic science with us
We partner with academic groups, biotech teams, and translational organizations to accelerate responsible gene therapy innovation.